ASTRALIS LTD
Business Summary
Astralis Ltd is a United States-based biotechnology company. The Company is engaged in research and development of treatments for immune system disorders and skin diseases, such as psoriasis and psoriatic and rheumatoid arthritis. The Company's initial product candidate, Psoraxine, is a protein extract used for the treatment of the skin disease psoriasis. The Company has one product in clinical development, and has pre-clinical focus in areas, including eczema, rheumatoid arthritis and leishmaniasis. Psoraxine, for the treatment of moderate to severe psoriasis, is in Phase II clinical trials.
Country of Incorporation
United States of America
Incorporation Date
2001-11-19
Business Sector
Pharmaceuticals & Medical Research
Company Address
135 Columbia Tpke Ste 301
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
